Pliant Therapeutics (PLRX) Change in Taxes (2019 - 2020)

Pliant Therapeutics (PLRX) reported Change in Taxes of -$178000.0 for Q2 2020, down 147.22% quarter-over-quarter from -$72000.0 in Q1 2020.

Pliant Therapeutics (PLRX) Change in Taxes (2019 - 2020) Analysis & Trends

Pliant Therapeutics (PLRX) has 2 years of Change in Taxes data on file, last reported at -$178000.0 in Q2 2020.

Change in Taxes for Q2 2020 came in at -$178000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was -$178000.0 (changed N/A YoY), and the FY2020 annual result was -$250000.0, down 49.7% from the prior year.
Change in Taxes declined to -$178000.0 in Q2 2020 per PLRX's latest filing, from -$72000.0 in the prior quarter.
Over five years, Change in Taxes peaked at $62000.0 in Q3 2019 and troughed at -$187000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change Taxes (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Pliant Therapeutics	71.07 Mn	71.07 Mn	-	-

Download Data